Pharmaceutical Business review

Omrix names new chairman

Mr Ellberger succeeds Fredric Price who served as Omrix’s chairman from January 2005. Mr Ellberger has been a member of the company’s board since August 2006 and was previously chairman of the compensation committee. He will continue to be a member of the audit committee and will chair the governance and nominating committee.

Ms McNamara will chair the compensation committee and be a member of the audit committee. Ms McNamara has been CEO of CRF, a clinical trial data management and mobile technology company, since October 2003.